Benzalkonium Chloride: BPR Status and Product Authorisation
In the webinar, the chemistry and biocidal activity of BKC are briefly discussed in addition to the current regulatory status under the biocidal products regulation (BPR).
What the session will cover?
Benzalkonium chloride (BKC or BAC) is a well-established active substance that has been used in biocidal formulations for several decades. In the webinar, the chemistry and biocidal activity of BKC are briefly discussed in addition to the current regulatory status under the biocidal products regulation (BPR). BKC has been approved for PT3 and 4 in the EU and is up for discussion at the Biocidal product committee meeting for PT1 and 2. Companies selling such products in Europe need to take appropriate action to ensure continuity on the market in the EU. This webinar will give you an overview of the steps required for product authorization.
Who should attend?
Anyone who works for a company that imports/manufactures/formulates a biocidal product or biocidal product containing BKC as an active substance.
Anyone with an interest in marketing such products in the EU or UK.
Anyone interested in the steps necessary for biocidal product authorisation.
Instructors
Aiden Robertson
Managing Consultant
Dr Aiden Robertson is a Managing Consultant here at Yordas and an experienced PhD chemist with over 7 years’ experience in chemicals regulation. His specialist area is supramolecular chemistry and solid-state analytical chemistry but his technical experience in both REACH and Biocides means that he has worked with a broad range of organic, inorganic and biological substances, polymers, minerals, petroleum products and formulations. He heads up the substance characterisation service here at Yordas, and has a great deal of experience working with nanoforms.
